【摘 要】
：
Objectives: Our study was designed to explore the influence of intravenous immunoglobulin (IVIG) and methylprednisolone (MP) on cytokines secreted by T lymphocyte in children ITP.Materials and methods
【机 构】
：
首都医科大学附属北京儿童医院 100045
【出 处】
：
中华医学会第15次全国血栓与止血学术会议
论文部分内容阅读
Objectives: Our study was designed to explore the influence of intravenous immunoglobulin (IVIG) and methylprednisolone (MP) on cytokines secreted by T lymphocyte in children ITP.Materials and methods: We enrolled children ITP at the onset of their disease from our department between December 2011 and March 2013.Cytokines measurement by cytometric bead array included IL-2, IL-4, IL-6, IL-10,TNF, IFN and IL-17.
其他文献
目的:对1个遗传性低纤维蛋白原血症的家系进行了表型诊断和基因分析,以探究该病的发病机制.方法:检测该家系所有成员外周血活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)、凝血酶时间(TT)、纤维蛋白原(Fg)活性用Clauss法测定,同时抽提所有成员外周血白细胞DNA,PCR扩增Fg3个基因FGA、FGB和FGG所有外显子及其侧翼序列,DNA测序并进行基因分析.结果:家族成员中先证者、先证者父
目的:对1例遗传性凝血因子Ⅴ缺乏症家系进行表型与基因分析,探讨其分子发病机制.方法:对先证者及其家系成员进行凝血功能、FV活性测定进行表型诊断;用PCR法对家系成员的FV基因的25个外显子及外显子、内含子的交界区序列进行酶联反应扩增,PCR产物纯化后直接测序,与标准序列比对检测其基因突变.
目的:血栓性疾病严重威胁着人类健康,近年来其遗传学病因越来越多的被报道.研究发现抑制APOC3的表达能显著降低血浆内载脂蛋白C3和甘油三酯的水平.在欧洲和非洲人群中,发现APOC3的一些突变(R19X,A43T,IVS2+1G →A,IVS3+1G→T)能降低血栓性疾病的风险.本实验目的在于研究APOC3与血栓性疾病在中国人群中的关联性.方法:本研究共对4470例中国人进行相关位点研究,包含148
Background: Thrombocytopaenia is a frequent complication of liver cirrhosis, andITP is closely related with H.pylori.Several studies illuminate the associations betweenH, pylori and viral hepatitis,bu
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominantly inherited vascular-malformation syndrome associated with gene mutations including ENG, ACVRL1 and SMAD4 gene.Clinically indisting
We have previously reported that human umbilical cord blood-derivedstromal cells (hUCBDSCs) are able to enhance the expansion of CFU-Meg in vitro, particularly promote the megakaryocytic lineage recov
Background: Chronic lymphocytic leukaemia (CLL) is generallytreated by chemoimmunotherapy, and there isan unmet medical need for noveltargeted therapies or combination therapies.Ibrutinib is an effici
Background: It is widely accepted that immune complex-mediated classical complement pathwayactivation represents an important mechanism of platelet destruction in immunethrombocytopaenia (ITP) (Peersc
Background: Rituximab is mostly used in patients with chronic refractory ITP who have failed multiple prior treatments, including splenectomy.Objective: The potential role of rituximab as an early the
目的:评价中小剂量达那唑治疗原发免疫性血小板减少症(ITP)的长期疗效和安全性.方法:回顾性分析了2010年1月至2014年12月间,319例应用中小剂量达那唑(200～300mg/d)治疗的成人ITP患者.患者单用达那唑或联合激素治疗.观察疗效和不良反应并分析影响疗效的相关因素.结果:319例患者中,新诊断ITP患者25例,持续性或慢性ITP患者294例,中位年龄51 (16～86)岁,男女比例